Effect of sampling time on somatic and germ cell mutations induced by acrylamide in gpt delta mice

• Published in: Genes and environment 2021-02, Vol.43 (1), p.4-12, Article 4
• Main Authors: Hagio, Soichiro, Tsuji, Naho, Furukawa, Satoshi, Takeuchi, Kazuya, Hayashi, Seigo, Kuroda, Yusuke, Honma, Masamitsu, Masumura, Kenichi
• Format: Article
• Language: English
• Subjects: Acrylamide; Amides; Assaying; Carcinogens; Deoxyribonucleic acid; DNA; Drinking water; Erythrocytes; Ethyl nitrosourea; Exposure; Gene mutations; Genetic aspects; Genetic research; Germ cell; Germ cells; gpt delta transgenic mouse; Lungs; Mutagenicity; Mutant frequency; Mutation; Peripheral blood; Plasmids; Point mutation; Rodents; Sampling; Somatic cells; Sperm; Spermatogenesis; Stem cell transplantation; Stem cells; Testes; Transgenic mice
• ISSN: 1880-7046; 1880-7062; 1880-7062
• DOI: 10.1186/s41021-021-00175-5

Acrylamide (AA) is a rodent carcinogen and classified by the IARC into Group 2A (probable human carcinogen). AA has been reported to induce mutations in transgenic rodent gene mutation assays (TGR assays), the extent of which is presumed to depend on exposure length and the duration of expression after exposure. In particular, it is not clear in germ cells. To investigate mutagenicity with AA in somatic and germ cells at different sampling times, we conducted TGR assays using gpt delta transgenic mice. The male gpt delta mice at 8 weeks of age were treated with AA at 7.5, 15 and 30 mg/kg/day by gavage for 28 days. Peripheral blood was sampled on the last day of the treatment for micronucleus tests and tissues were sampled for gene mutation assays at day 31 and day 77, those being 3 and 49 days after the final treatment (28 + 3d and 28 + 49d), respectively. Another group of mice was treated with N-Ethyl-N-nitrosourea (ENU) at 50 mg/kg/day by intraperitoneal administration for 5 consecutive days and tissues were sampled at the day 31 and day 77 (5 + 26d and 5 + 72d). Frequencies of micronucleated erythrocytes in the peripheral blood significantly increased at AA doses of 15 and 30 mg/kg/day. Two- to three-fold increases in gpt mutation frequencies (MFs) compared to vehicle control were observed in the testes and lung treated with 30 mg/kg/day of AA at both sampling time. In the sperm, the gpt MFs and G:C to T:A transversions were significantly increased at 28 + 3d, but not at 28 + 49d. ENU induced gpt mutations in these tissues were examined at both 5 + 26d and 5 + 72d. A higher mutant frequency in the ENU-treated sperm was observed at 5 + 72d than that at 5 + 26d. The gpt MFs in the testes, sperm and lung of the AA-treated mice were determined and compared between different sampling times (3 days or 49 days following 28 day-treatment). These results suggest that spermatogonial stem cells are less sensitive to AA mutagenicity under the experimental condition. Prolonged expression time after exposure to AA to detect mutagenicity may be effective in somatic cells but not in germ cells.